Therapeutic hepatitis B vaccine
Vaccine
Therapeutic hepatitis B vaccine is one of 47 biologic programs targeting Chronic Hepatitis B Virus Infection. It is currently in development.
1
Indications
1
Total Trials
1
Active Trials
46
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
82 competitors in Chronic Hepatitis B Virus Infection
#DrugCompanyPhaseTrials
1Tyzeka
NovartisPhase 3
Viread
GSKPhase 3
Baraclude
KKaruna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
Hepsera
Bristol-Myers SquibbPhase 3
PEG-Intron
Merck & Co.Phase 3
Levovir
BBukwang Pharmaceutical
Phase 3
Viread
GileadPhase 2
Vemlidy
GileadPhase 2
Opdivo
Bristol-Myers SquibbPhase 2
Imfinzi
AstraZenecaPhase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Vaccine[2]
- Company
- VVaxine Pty Ltd